1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Palbociclib Isethionate: new trials by email Literature Review of Palbociclib Isethionate trials Research Report on Palbociclib Isethionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial Axitinib, Crizotinib, Palbociclib Isethionate - Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 111 | 2020-12-01 | 2026-09-18 |
| Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors palbociclib isethionate, pharmacological study, laboratory biomarker analysis - Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma | Phase 1 | Terminated | Pediatric Brain Tumor Consortium | 35 | 2014-12-08 | 2021-03-02 |
Astrocytoma (1) · Choroid Plexus Neoplasms (1) · Glioblastoma (1) · Medulloblastoma (1) · Neoplasm Metastasis (1) · Neoplasms, Neuroepithelial (1) · Oligodendroglioma (1)
M.D. Anderson Cancer Center (1) · Pediatric Brain Tumor Consortium (1)
United States (2)
David Van Mater, MD (1) · Timothy A Yap (1)
U01CA081457 (1)